Pharmaceuticals, Biotechnology and Life Sciences
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it…
4D Molecular Therapeutics to host a conference call on November 3rd, 4:30 pm E.T.EMERYVILLE, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE)…
LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating…
Utilizing decades of experience, Paschal will bring his strategic leadership and technical know-how to Growcentia as the company continues to…
NEWARK, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology…
– Taysha Gene Therapies is an emerging leader in the development of AAV gene therapies; new collaboration aimed at enhancing…
Conference call and webcast on Tuesday, October 25 at 8:00 AM ETDALLAS, Oct. 24, 2022 (GLOBE NEWSWIRE) — Taysha Gene…
TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced…
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the closing of…
LONDON, Oct. 24, 2022 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a clinical-stage biopharmaceutical…